ABSTRACT: Platelet rich plasma (PRP) contains various cytokines and growth factors which may be beneficial to the healing process of injured muscle. The aim of this study was to investigate the effect and molecular mechanism of PRP on migration of skeletal muscle cells. Skeletal muscle cells intrinsic to Sprague-Dawley rats were treated with PRP. The cell migration was evaluated by transwell filter migration assay and electric cell-substrate impedance sensing. The spreading of cells was evaluated microscopically. The formation of filamentous actin (F-actin) cytoskeleton was assessed by immunofluorescence staining. The protein expressions of paxillin and focal adhesion kinase (FAK) were assessed by Western blot analysis. Transfection of paxillin small-interfering RNA (siRNAs) to muscle cells was performed to validate the role of paxillin in PRP-mediated promotion of cell migration. Dose-dependently PRP promotes migration of and spreading and muscle cells. Protein expressions of paxillin and FAK were up-regulated dose-dependently. F-actin formation was also enhanced by PRP treatment. Furthermore, the knockdown of paxillin expression impaired the effect of PRP to promote cell migration. It was concluded that PRP promoting migration of muscle cells is associated with up-regulation of proteins expression of paxillin and FAK as well as increasing F-actin formation. ß
Muscle injuries are common with an incidence varying between 10% and 55% of all injuries encountered in sports especially in competitive sports involving contact, sprinting, jumping, and acceleration activities. 1 Muscle injuries may account for the majority of missed days of practice in the elite athlete. 2 Despite the significance of muscle injury, the mainstay of treatment is mainly non-operative, thus allowing the body's native reparative function to heal. Common treatment options are rest from activities, the application of ice, compressive dressing, elevation of the injured limb, physical modalities, and medication. 3 Platelet rich plasma (PRP) contains various cytokines and growth factors observed in the healing muscle has been therefore suggested as potential treatment to accelerate the healing process of injured muscle.
PRP is defined as a volume of the plasma fraction of autologous blood having a platelet concentration above baseline. 4, 5 In clinical management of muscle injuries, the current hypothesis is that intramuscular injections of PRP deliver supra-physiological concentrations of cytokines and growth factors [6] [7] [8] at the injured site, influencing cell migration, proliferation, differentiation or fusion, and ultimately enhancing muscle regeneration. 9 PRP therapies may influence muscle regeneration by acting on the satellite cells, 10 whose activities are controlled by growth factors and other cytokines, including insulin-like growth factor (IGF), hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF). [11] [12] [13] [14] [15] [16] [17] Skeletal muscle healing after injury involves progressive overlapping cellular behaviors, such as proliferation, migration, and differentiation of muscle precursors. 18 Skeletal muscle satellite cells are documented to be a group of quiescent stem cells which are localized between the plasmalemma and the basement membrane of muscle fiber. Satellite cells play an important role in the repair of injured or inflamed muscle. 19, 20 Once satellite cells are activated after injury, they migrate to the injured site and differentiate to form new myofibers which fuse to each other or fuse to local surviving muscle fibers, contributing to muscle regeneration. Migration of skeletal muscle satellite cells across the basement membrane to access the injured site plays a fundamental role in muscle regeneration. [19] [20] [21] Paxillin is a 68-kDa cytoskeletal protein found in focal adhesions that occur at sites where cells adhere to the extracellular matrix (ECM). 22, 23 It was reported that paxillin as a positive regulator of cell mobility. 24 Paxillin is primarily within focal adhesions where transmembrane integrin molecules connect the actin cytoskeleton to the ECM, such as fibronectin. Associated with focal adhesion kinase (FAK), paxillin functions in transmitting signals downstream of integrins and controls important biological events including cell migration, proliferation, and survival. Paxillin is also tyrosine phosphorylated in response to integrinmediated cell adhesion and can be phosphorylated by FAK.
It has been demonstrated that PRP concomitantly up-regulates focal adhesion and cytoskeletal formation by increasing paxillin and actin fiber formation in human umbilical vein endothelial cells. 26 Whether PRP increases motility of skeletal muscle cells and its underlying molecular mechanism are waited to be investigated. Therefore, the aim of this study is to investigate the effect of PRP on migration of skeletal muscle cell and its association with expressions of paxillin, FAK as well as filamentous actin (F-actin) formation.
METHODS
All experimental procedures were approved by Institutional Animal Care and Use Committee of Chang Gung University (IACUC Approval No. CGU 12-089).
Collection and Preparation of PRP PRP was isolated by two-step manual platelet concentration method. Briefly, whole blood was collected from SpragueDawley (SD) rats (weighing 300 g) which provided by BioLasco Taiwan Co., Ltd. Rats were anesthetized under 5% isofluorane for 5 min and collected whole blood from the heart by using a 21 gauge needle. After collecting blood, rats were sacrificed by inhalation of carbon dioxide. Then blood pre-treated with acid citrate dextrose solution was centrifuged at 800g for 30 min to separate into plasma and erythrocyte fractions. Plasma was transferred to new tube, and the second centrifugation (3,000g for 20 min) of plasma was used to separate PRP (containing a high number of platelets) from PPP (containing few platelets). Isolated PRP was clotted by adding a 10% thrombin solution (v/v, 500 U/ml in 100 mM CaCl 2 ) for 30 min. After another centrifugation (5,500g for 15 min), the soluble PRP was isolated from the clotted preparations. These final PRP was filtered by ultrafiltration (0.22 mm) and used in the following experiments or was frozen to store at À20˚C for later use.
Primary Culture of Rat Gastrocnemius Muscle Cells
The gastrocnemius muscle was excised from SD rats (weighing 200-250 g) which provided by BioLasco Taiwan Co., Ltd. Rats were sacrificed by inhalation of carbon dioxide, and the gastrocnemius muscle was immediately excised. The surrounding fascia and adipose tissue were removed and each muscle was then cut into small pieces of approximately 1.5-2.0 mm 3 . These pieces were individually placed in 15 ml centrifuge tube. A total of 0.2% collagenase type I in TESCA buffer (50 mM TES, 0.36 mM CaCl 2 ) (Sigma-Aldrich, St. Louis, MO) was added to the culture plates and cells were incubated for 45 min at 37˚C in a humidified atmosphere of 5% CO 2 /95% air. Then cells were treated with 0.1% trypsin-EDTA (Gibco, Thermo Fisher Scientific, Waltham, MA) and were incubated for another 45 min. The supernatant was collected and undergo centrifuges with 1,000g for 5 min. Cell pallets were re-suspended with Dulbecco's modified Eagle's medium (DMEM) (Gibco, Thermo Fisher Scientific, Waltham, MA, USA), with 10% fetal bovine serum (FBS) (Gibco, Thermo Fisher Scientific), 5% chick embryo extract (Gibco, Thermo Fisher Scientific), 100 U/ml penicillin, and 100 g/ml streptomycin (Gibco, Thermo Fisher Scientific). After 1 h for fibroblast-shaped cells adhering to the plate, the non-adherent cells were transfer to another plate for further sub-culture and were incubated at 37˚C in a humidified atmosphere of 5% CO 2 /95% air. After incubation for 24 h, the supernatant were collected into 15 ml centrifuge tube and the adherent cells were washed with 1x PBS and cultured in DMEM with 10% FBS, 5% chick embryo extract. The supernatant containing skeletal muscle cells were centrifuged with 1,000g for 5 min. Then the cells were re-suspended and cultured in a 10 cm culture plate with DMEM with 10% FBS, 5% chick embryo extract. These cells were used for the following experiment.
Transwell Filter Migration Assay Cells were treated with 0.5%, 1%, and 2% PRP for 24 h and seeded at a density of 1 Â 10 5 cells per filter. Transwell filters (Costar, Corning, Cambridge, MA) with 8.0 mm pores were used for the migration assay. The inner chamber was filled with 250 ml serum free DMEM and the outer chamber was filled with 600 ml DMEM with 10% FBS. Cells were allowed to migrate for 3 h at 37˚C in an atmosphere of 95% air/5% CO2. The cells were stained with Liu's stain and then washed twice in PBS. Cells on the upper surface of the filter were removed using a cotton swab. Cells on the lower surface of the filter were counted under four random high-power microscopic fields (HPF) (100Â) per filter and the mean number of migrating cells calculated for each concentration.
In Vitro Wound Healing Model by Electric Cell-Substrate Impedance Sensing (ECIS)
The electric cell-substrate impedance sensing (ECIS) (Applied Biophysics Inc, Troy, NY) system was used to record cell migration activities during wound healing process. We seeded 1 Â 10 5 cells in 400 ml culture medium to each well of an ECIS electrode array (8W10E) at 37˚C in an atmosphere of 95% air/5% CO 2 overnight for cell attachment. After the monitor showed stable resistance (approximately 400-600 V), PRP was added into the culture medium for 24 h. Then the electrodes were activated to create 10 circular cell-free zones. After cells migrating into the cell-free zones and the resistance would change. The resistance level was recorded by multiple frequency/time (MFT) models and was analyzed from initial activated time to 6 h after cell plating. The relative resistance was normalized with initial activated resistance and control group as 100%.
Cell Spreading Assay
Cells were treated with 0.5%, 1%, and 2% PRP for 24 h and subcultured and plated on 6-cm culture dishes with DMEM containing 10% FBS to induce the cell adhesion and cell spreading. After plating for 30 min, cells were observed under light microscope (100Â and 200Â) and photographed. Under this condition, cells generally start to adhere onto the plate within 10 min and then spread out. Cells that remained round and with a much brighter appearance were considered as non-spread cells. Those with pseudopodia extensions were considered as spreading cells. The pseudopodia extensions of spread cells were clearly observed at 200Â. Percentages of spread cells per HPF were calculated. Three fields were randomly selected for observation.
Immunofluorescence Staining for Filamentous Actin (F-Actin) Skeletal muscle cells were seeded directly on the glass coverslips. The cells were untreated or treated with PRP for 24 h. Finally, the cells were fixed in 4% paraformaldehyde for 15 min. After washing three times in PBS, the glass coverslips were incubated in blocking solution (3% BSA in PBS) at PRP PROMOTES MUSCLE CELL MIGRATION room temperature for 1 h and incubated for 1 h with phalloidin conjugated FITC (Sigma) diluted in blocking solution. After washed in PBS, cells were stained in PBS containing 1 mg/ml DAPI for 5 min. After washed in PBS, the cells were examined under fluorescent microscope (200Â).
Western Blot Analysis
Cell extracts were prepared in lysis buffer containing 20 mM HEPES, 1 mM EDTA, 1 mM EGTA, 20 mM NaF, 1 mM Na 3 VO 4 , 1 mM Na 2 P 2 O 7 , 1 mM DTT, 0.5 mM PMSF, 1 mg/ml leupeptin, and 1% Triton X-100. Protein concentration of the cell extracts will be determined by Bradford assay (Bio-Rad Laboratories, Richmond, CA). Samples with identical protein quantities were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis, and transferred onto a PVDF membrane. The membranes were incubated at room temperature in blocking solution (5% BSA in PBS) for 1 h, followed by 2 h incubation in blocking solution containing an appropriate dilution of primary antibody, for example, mouse according to the manufacturer's protocol. After 48 h of transfection, the transfected cells were treated by 2% PRP for 24 h. Then Western blot analysis for assessing paxillin expression and transwell filter migration assay to evaluate muscle cell migration were performed.
Statistical Analysis
All data were expressed as mean AE standard error of mean (SEM). The Kruskal-Wallis test was used to comparisons between groups. A Mann-Whitney test was used to identify where the difference occurred. The level of statistical significance was set at a p-value less than 0.05.
RESULTS

Platelet Rich Plasma Enhanced Migration of Skeletal Muscle Cells
Skeletal muscle cells were treated with 0.5%, 1%, 2% PRP for 24 h and migration ability was assessed by transwell filter migration assay. The results revealed that PRP induced migration of skeletal muscle cells dose-dependently. The relative percentage of cells migrated across the filters were 100 AE 0%, 214 AE 23%, 264 AE 31%, 427 AE 57% in the control, 0.5%, 1%, and 2% PRP-treated group, respectively (p < 0.05; Fig. 1 ).
Platelet Rich Plasma Enhanced In Vitro Wound Healing of Skeletal Muscle Cells
The electric cell substrate impedance sensing (ECIS) equipment has been developed to record cell migration activities during in vitro wound healing model without interruption. The normalized impedance showed the wound healing rate of skeletal muscle cells was increased by PRP treatment (Fig. 2) . The normalized resistance of control group, muscle cells treated with 0.5%, 1%, and 2% PRP were 100.0 AE 0.0%, 138.2 AE 7.1%, 151.5 AE 12.7%, and 151.3 AE 23.6% (p < 0.05), respectively.
Platelet Rich Plasma Induced Spreading of Skeletal Muscle Cells
Cell attachment and spreading occur in the initial phase during cell migration process. We used cell spreading assay to examine the appearance of pseudopodia extension. The result showed cell spreading was enhanced by PRP (Fig. 3A) . It revealed that 69. Fig. 3B ).
PRP Modulated Formation of F-Actin in Skeletal Muscle Cells
In cell migration process, the migrating cells are driven by a dynamic filamentous actin (F-actin).
Immunofluorescence staining showed the F-actin as parallel fibers in cytoplasm and the formation of F-actin was induced by PRP in a dose-dependent manner (Fig. 4) .
PRP Up-Regulated Migration-Associated Proteins of Skeletal Muscle Cells
Skeletal muscle cells were untreated or treated with 0.5%, 1%, and 2% PRP for 24 h, and protein extracts were analyzed by Western blot analysis. The result showed protein expressions of FAK and paxillin were up-regulated at 24 h post PRP treatment in a dosedependent manner (Fig. 5) .
The Knockdown of Paxillin Expression Impaired PRP-Mediated Promotion of Muscle Cell Migration
The result of Western blot analysis revealed that the up-regulation of paxillin expression in muscle cells treated by PRP was not observed in muscle cells transfected with paxillin siRNA. In contrast, the up-regulation of paxillin expression of muscle cells by PRP was still significant in negative control siRNA group (Fig. 6A) . Furthermore, the effect of PRP to promote muscle cells migration assessed by transwell filter migration assay was significantly inhibited in muscle cells transfected with paxillin siRNA (p < 0.05) (Fig. 6B) . The relative percentage of cells migrating across the filters were 100.0 AE 0.0%, 298.0 AE 37.0%, 237.2 AE 22.1%, 47.8 AE 7.7% in the control, 2% PRPtreated, 2% PRP-treated with negative control siRNA, and 2% PRP-treated with paxillin siRNA group, respectively.
DISCUSSION
Autologous PRP was first applied in an open heart surgery by Ferrari et al. in 1987. 27 Since that time the use of autologous PRP has been safely applied to many medical fields including orthopedics, sports medicine, dentistry, cosmetic, cardiothoracic, and maxillofacial surgery. Platelets contain an abundance of growth factors, chemokines, and cytokines that are pivotal in soft tissue healing and bone mineralization. 28 Regarding the use of PRP to treat muscle injury, animal studies have been performed to support the use of PRP to treat muscle injury. A mice gastrocnemius contusion model was used to evaluate the role of the growth factors released from autologous platelet concentration support muscle healing. 29 It concluded that PRP could accelerate satellite cell activation and increased diameter of the regenerating fibers. Meanwhile, a study reported applying PRP to an eccentric muscle injury model in rats could obtain a significantly shortened time to full recovery. 30 Wright et al. demonstrated that autologous conditioned serum shortened the average time to recovery and accelerated muscle healing in athletes. 31 It was further demonstrated that a single autologous PRP injection combined with a rehabilitation program was significantly more effective in treating muscle injuries than a rehabilitation program alone. 32, 33 The healing process of an injured muscle is composed of three phases. 34 The first phase is breakdown and inflammatory (destruction) phase which is characterized by hematoma formation, muscle tissue necrosis, degeneration, and an inflammatory cell response. This phase starts several hours after injury. The second phase is regeneration (repair) phase including phagocytosis of the damaged tissue, regeneration of the striated muscle, production of connective scar tissue, and capillary ingrowth. Skeletal cell migration, PRP PROMOTES MUSCLE CELL MIGRATION proliferation and differentiation are key steps in this phase for muscle regeneration. 18 The onset of this phase takes place 24 h after injury, lasts up to several weeks and peaks in the second or third week. In the final remodeling phase, the regenerated muscle matures and contracts, and scar tissue is reorganized; however, an incomplete restoration of the functional capacity of the muscle often occurs. Promotion of muscle cell migration should therefore enhance muscle healing process.
Cell migration can be divided into three distinct stages; protrusion (spreading) in which lamellipodia and filipodia are extended forward over the extracellular matrix; attachment in which the actin cytoskeleton connects to the adhesion sites and interacts with other focal adhesion proteins; and traction in which the cell body moves forward. 35 PRP was also reported to enhance migration of human synovial fibroblasts, tenocytes, meniscus cells as well as osteoblasts. [36] [37] [38] [39] Our study revealed that PRP had a significant effect on promoting skeletal muscle cell spreading, and further enhancing cell migration. Meanwhile, the results of ECIS further confirmed that in vitro wound healing rate of skeletal muscle cells was also enhanced by PRP.
Paxillin can interact directly or indirectly with a number of proteins which have been implicated in regulating the cytoskeletal architecture and processes such as spreading and migration. For example, paxillin can bind directly to FAK which has been documented to be essential for focal adhesion turnover, spreading, migration, and survival. 40 Paxillin has also been linked to Cas via the adapter protein Crk, and Cas plays a role in cell migration. [41] [42] [43] In this study, the protein expressions of paxillin and FAK were upregulated by PRP. These findings imply that the regulation of protein expressions of paxillin and FAK might be a critical molecular mechanism for PRPinduced in vitro healing and migration of skeletal muscle cell.
This study is the first one to show that PRP increased the formation of F-actin in skeletal muscle cells. Dynamic regulation of the F-actin cytoskeleton plays a key role in numerous physical cellular processes, including cell adhesion, migration, and division. [44] [45] [46] It was reported that PRP increased chemokinesis and chemotaxis of osteoblast and concomitantly induced the organization of actin microfilaments by a transient increase in the expression of PGDF a receptor. 47 In living cells, the F-actin cytoskeleton encompasses a variety of different structures that are essential for many different aspects of cell physiology. It is possible that PRP modulates PDGF a receptor of skeletal muscle cells and thus re-organization of actin microfilament to increase the mobility of skeletal muscle cells.
Clinical effectiveness of PRP can be expected with a platelet concentration increasing up to four to sixfold (around 1 million platelets/ml). 5 In our experimental setting, the platelet count and concentration of platelet derived growth factor (PDGF) are 3.81-fold and 4.26-fold higher than normal whole blood, respectively. 48 This study revealed that the effect of PRP to promote migration of skeletal muscle cell was significant. To the best of our knowledge, this study was the first to demonstrate, in a dose dependent manner, PRP promoted migration of skeletal muscle cells in association with the up-regulation of expressions of paxillin and FAK as well as increasing the formation of F-actin. These findings hold promise that PRP therapies can accelerate muscle healing and returning the elite athlete to competition earlier.
In conclusion, these findings provide novel information implicating the molecular mechanism of PRP to enhance muscle cell migration. PRP promotes migration of skeletal muscle cells in association with the up-regulation of expressions of paxillin and FAK as well as increased the formation of F-actin. Furthermore, the knockdown of paxillin expression impairs PRP-mediated promotion of muscle cell migration. These findings provide laboratory based evidences to support the use of PRP to treat muscle injury.
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